Injection-meal interval: recommendations of diabetologists and how patients handle it.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8227(98)00132-6PMID 10221666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Social status and the quality of care for adult people with Type I (insulin-dependent) diabetes mellitus – a population-based study

  1998cited by this paper
• [Lys(B28), Pro(B29)]‐human insulin: Effect of injection time on postprandial glycemia

  1995cited by this paper
• Do Insulin‐treated Diabetic Patients Use an Injection‐meal‐interval in Daily Life?

  1995cited by this paper
• Quality assessment of diabetes care according to the recommendations of the St. Vincent Declaration: A population-based study in a rural area of Austria

  1992cited by this paper
• Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal.

  1992cited by this paper
• The Importance of the Time Interval Between Insulin Injection and Breakfast in Determining Postprandial Glycaemic Control—A Comparison Between Human and Porcine Insulin

  1988cited by this paper
• Free insulin profiles during intensive treatment with biosynthetic human insulin.

  1988cited by this paper
• [Optimum time of insulin therapy in type I diabetes mellitus].

  1986cited by this paper
• Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy.

  1985cited by this paper
• Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.

  1985influential reference
• Meal intolerance in type 1 diabetes mellitus: influence of time interval between insulin therapy and meal intake.

  1984cited by this paper
• Praxis der Insulintherapie

  1983cited by this paper
• Insulin delivery with meals. Plasma insulin profiles after bolus injection of human or porcine neutral insulin.

  1983cited by this paper
• Roles of site and timing of the morning insulin injection in type 1 diabetes.

  1983cited by this paper
• Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

  1983cited by this paper
• Timing of Insulin Delivery with Meals

  1981cited by this paper
• Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose.

  1981cited by this paper
• Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children

  1980cited by this paper

• Rapid-Acting Insulin Analogues: Theory and Best Clinical Practice in Type 1 and Type 2 Diabetes.

  2022cites this paper
• Comparative assessment of modern parameters of glycemic control in children with type 1 diabetes after switching to fast-acting insulin aspart using Flash Glucose Monitoring in real clinical practice

  2022cites this paper
• What is the value of faster acting prandial insulin? Focus on ultra rapid lispro

  2022cites this paper
• Injection Site Massage to Improve the Pharmacokinetics of Aspart in Obese Adolescents with Diabetes

  2021influential citation
• The impact of "faster aspart" on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump.

  2021cites this paper
• Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes

  2020cites this paper
• [The impact of «faster aspart» on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump].

  2020cites this paper
• Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences

  2019cites this paper
• Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.

  2018cites this paper
• Pharmakologische Eigenschaften des schneller wirksamen Insulins aspart (Faster-acting Insulin aspart)

  2017cites this paper
• POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY.

  2017cites this paper
• Pharmacological Properties of Faster-Acting Insulin Aspart

  2017cites this paper
• A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes

  2017cites this paper
• Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus

  2016cites this paper
• Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

  2016cites this paper
• Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals

  2015cites this paper
• Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience

  2015cites this paper
• Diabetes Interactive Diary: A Mobile Phone-Based Telemedicine System for Carbohydrate Counting and Bolus Calculator

  2015cites this paper
• Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

  2015cites this paper
• Subcutaneous insulin therapy - end of the road after 80 years?

  2014cites this paper
• Insulin aspart revisited: new and clinical differential aspects versus other rapid-acting insulin analogs

  2013cites this paper
• A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Preprandial and Prandial Insulin in Combination with Acarbose in Elderly, Insulin-Requiring Patients with Type 2 Diabetes Mellitus

  2013cites this paper
• RandomizedCrossover Study to Examine the Necessity of an Injection-to-Meal Interval inPatientsWithType2Diabetes Mellitus and Human Insulin

  2013cites this paper
• Ten years of NovoMix 30 in Russian and international clinical practice

  2013cites this paper
• Randomized Crossover Study to Examine the Necessity of an Injection-to-Meal Interval in Patients With Type 2 Diabetes and Human Insulin

  2013cites this paper
• Десять лет применения в мире и в России инсулина НовоМикс 30

  2013cites this paper
• Impact of the “Diabetes Interactive Diary” Telemedicine System on Metabolic Control, Risk of Hypoglycemia, and Quality of Life: A Randomized Clinical Trial in Type 1 Diabetes

  2013cites this paper
• Clinical Performance of a Device That Applies Local Heat to the Insulin Infusion Site: A Crossover Study

  2012cites this paper
• Therapie des Typ-1-Diabetes

  2012cites this paper
• İnsülin Analoglarinin Diyabetes Mellitus Tedavisindeki Rolü ve Faydalari Role and Benef its of Insulin Analogues in the Treatment of Diabetes Mellitus

  2012cites this paper
• Therapie des Typ-1-Diabetes1

  2012cites this paper
• Biphasic insulin analog NovoMix 30 is a possible solution to overcome key problems of biphasic human insulin therapy for DM type 2 patients

  2012cites this paper
• İnsülin Analoglarının Diyabetes Mellitus Tedavisindeki Rolü ve Faydaları

  2012cites this paper
• Aspectos básicos de la insulina aspart: ventajas potenciales derivadas de su mayor estabilidad fisicoquímica

  2012cites this paper
• A Comparison of Pharmacokinetics and Pharmacodynamics of Insulin Aspart, Biphasic Insulin Aspart 70, Biphasic Insulin Aspart 50, and Human Insulin: A Randomized, Quadruple Crossover Study

  2012cites this paper
• Ultrafast-Acting Insulins: State of the Art

  2012cites this paper
• Insulin initiation in type 2 diabetes: What are the treatment regimen options and how can we best help patients feel empowered?

  2012cites this paper
• Эффективный и безопасный контроль гликемии с помощью инсулина глулизин

  2011cites this paper
• Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine.

  2011cites this paper
• Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review.

  2011cites this paper
• Reduction of Postprandial Glycemic Excursions in Patients with Type 1 Diabetes: A Novel Human Insulin Formulation versus a Rapid-Acting Insulin Analog and Regular Human Insulin

  2011cites this paper
• Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096)

  2011cites this paper
• Glycemic Control with Preprandial Versus Basal Insulin in Patients with Type 2 Diabetes Mellitus Poorly Controlled by Oral Antidiabetes Agents

  2010cites this paper
• Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.

  2010cites this paper
• Analogues et dosages d’insuline : le cas général et le cas particulier de la glargine

  2010cites this paper
• Insulin Pump Therapy: What is the Evidence for Using Different Types of Boluses for Coverage of Prandial Insulin Requirements?

  2009cites this paper
• Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes

  2009cites this paper
• Biphasic Insulin Aspart 30 : Premix Analogue for Initiating Insulin Therapy in Type 2 Diabetes

  2009cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glulisine

  2008cites this paper
• New Insulin Analogues and Routes of Delivery

  2008cites this paper
• Initiating Insulin Therapy in Type 2 Diabetes: Benefits of Insulin Analogs and Insulin Pens

  2008cites this paper
• Initiating insulin in primary care--the role of modern premixed formulations.

  2008cites this paper
• Using prandial insulin to achieve glycemic control in type 2 diabetes.

  2007cites this paper
• Insulin aspart: rapid control for postmeal glucose excursions

  2007cites this paper
• Potential Advantages of a Basal–Bolus Regimen Using Insulin Glulisine as Prandial Insulin

  2007cites this paper
• Premixed insulin treatment for type 2 diabetes: analogue or human?

  2007cites this paper
• Combining insulins for optimal blood glucose control in type 1 and 2 diabetes: Focus on insulin glulisine

  2007cites this paper
• Getting closer to physiologic insulin secretion.

  2007cites this paper
• Basal‐Prandial Insulin: When is the Right Time to Initiate Treatment?

  2007cites this paper
• Review: Insulin glulisine — the potential for improved glycaemic control

  2007cites this paper
• Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

  2007cites this paper
• Inhaled human insulin: a clinical perspective

  2006cites this paper
• Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes.

  2006cites this paper
• Targeting postprandial hyperglycemia.

  2006cites this paper
• Inhaled insulin (Exubera®): combining efficacy and convenience

  2006cites this paper
• Inhaled human insulin.

  2006cites this paper
• Physiologic Insulin Replacement in Type 2 Diabetes

  2006cites this paper
• Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes

  2006cites this paper
• Achieving goal glycosylated hemoglobin levels in type 2 diabetes mellitus: Practical strategies for success with insulin therapy

  2006cites this paper
• Insulin aspart: a review

  2006cites this paper
• Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities.

  2006cites this paper
• Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

  2005cites this paper
• New Insulin Analogues

  2005cites this paper
• Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.

  2005cites this paper
• Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargine.

  2005cites this paper
• Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.

  2005cites this paper
• A new cause of neuroglycopenia: ‘missing the point’

  2004cites this paper
• Exubera inhaled insulin: a review

  2004cites this paper
• Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.

  2004cites this paper
• Insulinothérapie : Nouvelles molécules et voies d’administration

  2004cites this paper
• Insulin Aspart

  2004cites this paper
• Newer Insulins : Making Early Insulin Initiation Safer and Simpler

  2004cites this paper
• Hypoglycaemia with insulin aspart: a double‐blind, randomised, crossover trial in subjects with Type 1 diabetes

  2004cites this paper
• [Biotechnological and administration innovations in insulin therapy].

  2004cites this paper
• Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes

  2003cites this paper
• Effect of the rapid‐acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes

  2003cites this paper
• Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

  2002cites this paper
• Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes.

  2002cites this paper
• Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.

  2002cites this paper
• New insulins in the treatment of diabetes mellitus.

  2002cites this paper
• Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study.

  2001cites this paper
• Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment.

  2001cites this paper
• Improving post-prandial control with Humalog and Humalog mixtures.

  2000cites this paper
• Inha led Human Insu l in ( Exubera ® ) :

  year unknowncites this paper